Calculate Your BMI & GLP-1 Weight Loss Projection

What is BMI?

Body Mass Index (BMI) is a screening tool that uses your height and weight to estimate body fat. While not perfect — it doesn't account for muscle mass, bone density, or body composition — it's widely used by healthcare providers as a starting point for assessing weight-related health risks.

Who qualifies for GLP-1 weight loss medications?

FDA guidelines generally approve GLP-1 medications for adults with:

• BMI ≥ 30 (obese) — eligible for weight loss medications
• BMI ≥ 27 (overweight) with at least one weight-related condition (type 2 diabetes, high blood pressure, high cholesterol, sleep apnea)

Always consult with a healthcare provider to determine if GLP-1 medications are appropriate for you.

How much weight can you lose with GLP-1 medications?

Clinical trials have shown impressive results:

• Semaglutide (Wegovy): Average 15% total body weight loss over 68 weeks (STEP 1 trial)
• Tirzepatide (Zepbound): Average 21% total body weight loss over 72 weeks (SURMOUNT-1 trial)
• Liraglutide (Saxenda): Average 8% total body weight loss over 56 weeks (SCALE trial)